NCT05155800View on ClinicalTrials.gov

A Study to Test the SENSE Device in Military-Age Patients With Traumatic Brain Injury

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

December 28, 2021

Primary Completion Date

October 17, 2023

Study Completion Date

November 15, 2023

Conditions
Traumatic Brain Injury
Interventions
DEVICE

SDx3

The SENSE Device (SDx3) is a non-invasive device that detects differences in the absorption of transmitted RF energy across the skull and brain and is intended to be used to evaluate intracranial hemorrhage.

Trial Locations (2)

30303

Grady, Atlanta

45219

UC Health, Cincinnati

All Listed Sponsors
lead

Sense Diagnostics, LLC

INDUSTRY

NCT05155800 - A Study to Test the SENSE Device in Military-Age Patients With Traumatic Brain Injury | Biotech Hunter | Biotech Hunter